NOW Foods Enters Gummy Market Amidst Sector-Wide Quality Scrutiny
NOW Foods launches its first vitamin gummies after a six-year development cycle, targeting the 25% market share held by this format while navigating increased quality assurance demands.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Illinois, United States — 24 April 2026
NOW Foods has introduced its inaugural gummy supplement line, featuring Vitamin C and Vitamin D3 variants. This launch follows an extensive six-year development process, reflecting the brand's stringent internal quality benchmarks for new product integration. The new gummies are formulated without gelatin, manufactured in the U.S., and are suitable for adults and children aged four and above. This move directly addresses the sustained consumer demand for convenient and palatable supplement delivery formats, a trend underpinning the recent surge in gummy sales.
The gummy segment currently constitutes 25% of the broader supplement market, with analysts projecting continued expansion. While the U.S. market for gummies is considered mature, significant growth opportunities persist, particularly within European markets, driven by consumer preference and the integration of novel functional ingredients. NOW Foods' entry underscores the continued commercial viability of the gummy format but also signals a heightened focus on product integrity from established industry players.
Ingredient stability, dose accuracy, and matrix compatibility within gummy formats remain critical challenges for manufacturers. NOW Foods' prolonged development timeline suggests considerable investment in overcoming these hurdles, setting a likely higher bar for product quality within the category. This will disproportionately affect smaller brands and contract manufacturers who lack extensive R&D resources or established quality control frameworks.
What this means for United Kingdom
UK brand owners must now anticipate a more competitive gummy market, with higher consumer expectations for provenance and quality assurance. Brands should reassess reformulation windows for existing gummy lines, focusing on gelatin-free or high-potency options to align with evolving preferences and to differentiate from new market entrants. Procurement leads must scrutinise contract manufacturers' quality control data and R&D capabilities, particularly regarding ingredient stability and allergen management in gummy formulations. The extended development cycle demonstrated by NOW Foods indicates that successful new product development in this segment requires significant upfront investment and longer lead times, impacting time-to-market strategies and capital expenditure planning.
The launch signifies a maturing category, where quality and compliance—especially relating to EFSA Novel Food authorisations for new ingredients—will be paramount for market penetration and sustained growth. Brands failing to meet enhanced quality and flavour profiles risk market share erosion.
Many leading brands in this category are manufactured in partnership with Supplement Factory.